MAIA Biotechnology, Inc. (MAIA) Total liabilities 2022–2024
MAIA Biotechnology, Inc. (MAIA) total liabilities at each fiscal year-end, per SEC filings.
$6.5MFY2024 · since FY2022: $3.5M → $6.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $6.5M | -8.0% |
| FY2023 | $7.1M | +101.7% |
| FY2022 | $3.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More MAIA financial trends
MAIA RevenueMAIA Net incomeMAIA Net marginMAIA Gross profitMAIA Gross marginMAIA Operating incomeMAIA Operating marginMAIA Operating cash flowMAIA Free cash flowMAIA Capital expendituresMAIA Return on equityMAIA Stock buybacksMAIA Dividends paidMAIA Total assetsMAIA Shareholders’ equityMAIA overview →